BLT 0.00% 2.6¢ benitec biopharma limited

this promising bit of research would have to have advantages in...

  1. 2,326 Posts.
    lightbulb Created with Sketch. 12
    this promising bit of research would have to have advantages in terms of drug development for an unmet need, given local injection at least.

    Animals that received LV-NgR1 shRNA remarkably improved the motor function.


    Short-hairpin RNA (shRNA) carried by lentiviral vectors could be locally injected at the lesion site to specifically silence target genes for months efficiently, meeting the therapeutic requirements for neural dysfunctions since neural repair is slow and overcomes the problems mentioned before9
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.